Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-05-05Clinical Trial Update: An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1) [Phase 3]
Phase 3 trial evaluating the efficacy and safety of telaprevir in patients with chronic hepatitis C co-infected with HIV-1. The study status…
-
CLINICAL_TRIALS trial_result · 2016-05-05Clinical Trial Update: Effect of HCV Infection on Insulin Resistance and Malnutrition-inflammation Complex Syndrome in Regular Hemodialysis Patients
This completed clinical trial investigates the impact of hepatitis C virus infection on insulin resistance and malnutrition-inflammation com…
-
CLINICAL_TRIALS trial_result · 2016-05-04Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MK-3281 in Healthy and Hepatitis C Infected Male Participants (MK-3281-002) [Phase 1]
Phase 1 trial evaluating safety, tolerability, and pharmacokinetics of MK-3281 in healthy and hepatitis C infected male participants has com…
-
CLINICAL_TRIALS trial_result · 2016-04-27Clinical Trial Update: Dose Escalation Study to Evaluate the Safety and Antiviral Activity of Val-mCyd in Adults With Chronic Hepatitis C [Phase 1, Phase 2]
A completed Phase 1/2 dose-escalation trial evaluating the safety and antiviral activity of Val-mCyd in adults with chronic hepatitis C.
-
CLINICAL_TRIALS trial_result · 2016-04-26Clinical Trial Update: Study of a New MVA Vaccine for Hepatitis C Virus [Phase 1]
A Phase 1 study of a novel MVA vaccine for hepatitis C has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-04-25Clinical Trial Update: Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease
Clinical trial evaluating a biological therapy's effect on biomarkers in untreated Hepatitis C, metastatic melanoma, and Crohn's disease was…
-
CLINICAL_TRIALS research · 2016-04-22Clinical Trial Update: Rifaximin to Prevent Recurrent HCV-Related Fibrosis After Liver Transplant [Phase 2]
A Phase 2 trial from Columbia University evaluating rifaximin to prevent recurrent HCV-related liver fibrosis after liver transplant; curren…
-
CLINICAL_TRIALS research · 2016-04-21Clinical Trial Update: Cognitive Impairments in Chronic Hepatitis C Patients and Potential Reversibility With New Agents (CICHepC) [Phase 4]
Phase 4 clinical trial investigating cognitive impairments in chronic hepatitis C patients and whether new agents can reverse them.
-
CLINICAL_TRIALS trial_result · 2016-04-20Clinical Trial Update: Pharmacokinetics, Pharmacodynamics and Safety of DEB025 Plus Ribavirin in Chronic Hepatitis C Genotype 2 and 3 Treatment naïve Patients [NA]
Completed clinical trial update reporting pharmacokinetics, pharmacodynamics, and safety data for DEB025 (alisporivir) in combination with r…
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: 4 Week Combination of BI 207127 NA With Peg-IFN and Ribavirin in Chronic HCV Patients [Phase 1]
Phase 1 study from Boehringer Ingelheim evaluating a 4-week combination of BI 207127 with Pegylated interferon and ribavirin in patients wit…
-
CLINICAL_TRIALS trial_result · 2016-04-19Clinical Trial Update: Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C Virus [NA]
A completed pilot trial evaluating a three-drug regimen—Daclatasvir, Asunaprevir, and BMS-791325—with or without Ribavirin for Hepatitis C.
-
CLINICAL_TRIALS trial_result · 2016-04-18Clinical Trial Update: IFN-free Combination Therapy in HCV-infected Patients Treatment-naive:HCVerso1 [Phase 3]
Phase 3 trial of an interferon-free combination therapy for treatment-naive chronic hepatitis C patients (HCVerso1) completed with results p…
-
CLINICAL_TRIALS trial_result · 2016-04-18Clinical Trial Update: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With COPEGUS (Ribavirin) in Interferon-Naive Patients With Chronic Hepatitis C Infection (CHC). [Phase 4]
A Phase 4 study assessing peginterferon alfa-2a with ribavirin in interferon-naive patients with chronic hepatitis C; results were posted in…
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: Ledipasvir/Sofosbuvir Fixed-Dose Combination + Ribavirin in Subjects With Chronic HCV With Advanced Liver Disease or Post-Liver Transplant [Phase 2]
Phase 2 trial evaluating a fixed-dose combination of ledipasvir/sofosbuvir with ribavirin in adults with chronic hepatitis C and advanced li…
-
CLINICAL_TRIALS trial_result · 2016-04-13Clinical Trial Update: This Trial Evaluates Safety, Pharmacokinetic Profile and Anti-viral Response of BI 207127 and BI 201335 for Patients With Chronic Hepatitis C [Phase 2]
Phase 2 trial evaluating safety, pharmacokinetics, and antiviral response of Boehringer Ingelheim compounds BI-207127 and BI-201335 in patie…
-
CLINICAL_TRIALS trial_result · 2016-04-12Clinical Trial Update: Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Chronic Hepatitis C Virus Infection Without Cirrhosis [Phase 3]
Phase 3 trial evaluating the efficacy and safety of combining Simeprevir with Sofosbuvir in adults with chronic hepatitis C without cirrhosi…
-
CLINICAL_TRIALS trial_result · 2016-04-12Clinical Trial Update: Study of Efficacy and Safety of Grazoprevir (MK-5172)/Elbasvir (MK-8742) Combination Regimen for Treatment-Naïve Participants With Chronic Hepatitis C Virus Genotypes 1, 4, and 6 (MK-5172-060) [Phase 3]
Phase 3 study of grazoprevir/elbasvir in treatment-naïve chronic hepatitis C patients showed completed results with posted outcomes in 2016.
-
CLINICAL_TRIALS trial_result · 2016-04-12Clinical Trial Update: Safety and Efficacy of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in Participants With Chronic Hepatitis C and Chronic Kidney Disease (MK-5172-052) [Phase 2, Phase 3]
A Phase 2/Phase 3 trial evaluating the safety and efficacy of Grazoprevir and Elbasvir in participants with chronic hepatitis C and chronic …
-
CLINICAL_TRIALS trial_result · 2016-04-11Clinical Trial Update: Hepatitis C Translating Initiatives for Depression Into Effective Solutions [NA]
This VA-sponsored trial evaluating interventions for depression in people with Hepatitis C has completed, and its results were posted in Apr…
-
CLINICAL_TRIALS trial_result · 2016-04-11Clinical Trial Update: Paroxetine for the Treatment of Interferon Related Side Effects for Hepatitis C [NA]
Completed clinical trial assessing paroxetine for managing interferon-related side effects in hepatitis C, with depression noted as a coexis…
-
CLINICAL_TRIALS research · 2016-04-08Clinical Trial Update: Study to Investigate Tolerability and Efficacy of MK5172 / MK8742 Without Ribavirin for 12 Weeks in Patients With Chronic HCV G1b Infection With Compensated Cirrhosis [Phase 3]
Phase 3 study assessing tolerability and efficacy of a ribavirin-free regimen of grazoprevir and elbasvir for 12 weeks in patients with chro…
-
CLINICAL_TRIALS trial_result · 2016-04-08Clinical Trial Update: Follow-up Study of Patients Who Experienced Thromboembolic Events in the ENABLE Studies
This is a clinical trial update describing a follow-up study of patients who experienced thromboembolic events in the ENABLE studies for Hep…
-
CLINICAL_TRIALS trial_result · 2016-04-07Clinical Trial Update: A Study of the Efficacy and Safety of PPI-668 (NS5A Inhibitor) Plus Sofosbuvir, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype-4 [Phase 2, Phase 3]
This clinical trial update outlines a combined Phase 2/3 study of PPI-668 (NS5A inhibitor) with Sofosbuvir, with or without Ribavirin, for c…
-
CLINICAL_TRIALS trial_result · 2016-04-05Clinical Trial Update: SYREN Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin) in Non-Responder Patients With Chronic Hepatitis C (CHC) Genotype 1. [Phase 4]
This trial update reports on the Phase 4 SYREN study evaluating PEGASYS (peginterferon alfa-2a, 40 kDa) plus Copegus (ribavirin) in non-resp…
-
CLINICAL_TRIALS trial_result · 2016-04-04Clinical Trial Update: Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Genotype 1 Chronic Hepatitis C Virus Infection and Cirrhosis [Phase 3]
Phase 3 trial evaluating the efficacy and safety of combining simeprevir with sofosbuvir in genotype 1 chronic hepatitis C with cirrhosis; r…